Breaking News, Promotions & Moves

Sterling Pharma Solutions Taps Karl Rotthier as CEO

Rotthier is a highly experienced CEO who has worked in both listed and private CDMO companies in Europe and globally.

Author Image

By: Charlie Sternberg

Associate Editor

Karl Rotthier.

Sterling Pharma Solutions has appointed Karl Rotthier as Chief Executive Officer (CEO), effective 21 October, 2025. Rotthier succeeds Kevin Cook, who has served as CEO since 2013 and decided to retire. Cook will work closely with Rotthier to ensure a smooth leadership transition. Chris Brinsmead CBE, Chair of the Sterling Board, said, “We are delighted to welcome Karl to Sterling Pharma Solutions. Karl is a highly experienced CEO who has worked in both listed and private CDMO companies in Eur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters